Rare diseases
Investigational molecules
Locations
Asciminib in Pediatric Patients With Philadelphia Positive Chronic Myeloid Leukemia in Chronic Phase
PolandLong-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
PolandObrixtamig, Carboplatin, and Etoposide for First-Line Treatment of Advanced Extrapulmonary Neuroendocrine Carcinoma in DLL3-Positive Patients
PolandICP-332 for Adults with Prurigo Nodularis
PolandRO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes
PolandA Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer
PolandLong-Term Study of Imeroprubart in Adults With Graves' Disease
PolandBMN 333 Versus Vosoritide in Children With Achondroplasia
PolandAZD0120 versus standard regimens in patients with relapsed or refractory multiple myeloma
PolandA study to evaluate the safety and effectiveness of MB-001 in adults with moderate to severe ulcerative colitis
PolandA study to evaluate the efficacy and safety of rilzabrutinib in adults with active IgG4-related disease
PolandA study to evaluate the effectiveness and safety of clemizole hydrochloride as an additional treatment for patients with Lennox-Gastaut syndrome
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
